Cargando…

Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms

BACKGROUND: Psychiatric prescribers (prescribers) typically assess medication adherence by patient or caregiver self-report. Despite likely clinical benefit of a new digital medicine technology, the role of specific prescriber attitudes, behaviors, and experiences in the likelihood of adoption is un...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruetsch, Charles, Davis, Tigwa, Liberman, Joshua N, Velligan, Dawn I, Robinson, Delbert, Jaeger, Chris, Carpenter, William, Forma, Felica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687687/
https://www.ncbi.nlm.nih.gov/pubmed/34938079
http://dx.doi.org/10.2147/NDT.S318344
_version_ 1784618224469409792
author Ruetsch, Charles
Davis, Tigwa
Liberman, Joshua N
Velligan, Dawn I
Robinson, Delbert
Jaeger, Chris
Carpenter, William
Forma, Felica
author_facet Ruetsch, Charles
Davis, Tigwa
Liberman, Joshua N
Velligan, Dawn I
Robinson, Delbert
Jaeger, Chris
Carpenter, William
Forma, Felica
author_sort Ruetsch, Charles
collection PubMed
description BACKGROUND: Psychiatric prescribers (prescribers) typically assess medication adherence by patient or caregiver self-report. Despite likely clinical benefit of a new digital medicine technology, the role of specific prescriber attitudes, behaviors, and experiences in the likelihood of adoption is unclear. OBJECTIVE: To identify prescriber characteristics that may affect adoption of the ingestible event marker (IEM) platform. DESIGN: A survey of prescribers treating seriously mentally ill patients was conducted. Factor analysis was performed on 11 items representing prescriber characteristics believed to be related to endorsement of the IEM platform. Four factors were extracted. Regression analysis was used to test the strength of the relationships between the factors and likelihood of adoption of the IEM platform. RESULTS: A total of 131 prescribers completed the survey. Most (84%) agreed that visits allow enough time to monitor adherence. Factor analysis revealed four underlying dimensions: 1) perspectives on the value of adherence; 2) concerns about measuring adherence; 3) views toward digital health technologies; and 4) views on payer role/reimbursement. Factors 1 and 3 were related to gender, the belief that computerization benefits prescribers, the presence of office support staff, and the belief that new digital medicine (DM) technology will be cost prohibitive. Willingness to adopt the IEM platform was related to gender (p < 0.05) and perspectives on the value of adherence (p < 0.05), with those scoring higher on that measure also being more likely to adopt. CONCLUSION: Psychiatric prescribers are concerned about medication adherence, perceive current monitoring tools to be problematic, and are open to using digital technologies to improve accuracy of adherence assessment. Relationships among prescriber characteristics, beliefs, and experiences should be considered when developing educational materials, particularly when the goal is to encourage adoption and use of the IEM platform.
format Online
Article
Text
id pubmed-8687687
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86876872021-12-21 Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms Ruetsch, Charles Davis, Tigwa Liberman, Joshua N Velligan, Dawn I Robinson, Delbert Jaeger, Chris Carpenter, William Forma, Felica Neuropsychiatr Dis Treat Original Research BACKGROUND: Psychiatric prescribers (prescribers) typically assess medication adherence by patient or caregiver self-report. Despite likely clinical benefit of a new digital medicine technology, the role of specific prescriber attitudes, behaviors, and experiences in the likelihood of adoption is unclear. OBJECTIVE: To identify prescriber characteristics that may affect adoption of the ingestible event marker (IEM) platform. DESIGN: A survey of prescribers treating seriously mentally ill patients was conducted. Factor analysis was performed on 11 items representing prescriber characteristics believed to be related to endorsement of the IEM platform. Four factors were extracted. Regression analysis was used to test the strength of the relationships between the factors and likelihood of adoption of the IEM platform. RESULTS: A total of 131 prescribers completed the survey. Most (84%) agreed that visits allow enough time to monitor adherence. Factor analysis revealed four underlying dimensions: 1) perspectives on the value of adherence; 2) concerns about measuring adherence; 3) views toward digital health technologies; and 4) views on payer role/reimbursement. Factors 1 and 3 were related to gender, the belief that computerization benefits prescribers, the presence of office support staff, and the belief that new digital medicine (DM) technology will be cost prohibitive. Willingness to adopt the IEM platform was related to gender (p < 0.05) and perspectives on the value of adherence (p < 0.05), with those scoring higher on that measure also being more likely to adopt. CONCLUSION: Psychiatric prescribers are concerned about medication adherence, perceive current monitoring tools to be problematic, and are open to using digital technologies to improve accuracy of adherence assessment. Relationships among prescriber characteristics, beliefs, and experiences should be considered when developing educational materials, particularly when the goal is to encourage adoption and use of the IEM platform. Dove 2021-12-16 /pmc/articles/PMC8687687/ /pubmed/34938079 http://dx.doi.org/10.2147/NDT.S318344 Text en © 2021 Ruetsch et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ruetsch, Charles
Davis, Tigwa
Liberman, Joshua N
Velligan, Dawn I
Robinson, Delbert
Jaeger, Chris
Carpenter, William
Forma, Felica
Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
title Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
title_full Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
title_fullStr Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
title_full_unstemmed Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
title_short Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
title_sort prescriber attitudes, experiences, and proclivities toward digital medicine and how they influence adoption of digital medicine platforms
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687687/
https://www.ncbi.nlm.nih.gov/pubmed/34938079
http://dx.doi.org/10.2147/NDT.S318344
work_keys_str_mv AT ruetschcharles prescriberattitudesexperiencesandproclivitiestowarddigitalmedicineandhowtheyinfluenceadoptionofdigitalmedicineplatforms
AT davistigwa prescriberattitudesexperiencesandproclivitiestowarddigitalmedicineandhowtheyinfluenceadoptionofdigitalmedicineplatforms
AT libermanjoshuan prescriberattitudesexperiencesandproclivitiestowarddigitalmedicineandhowtheyinfluenceadoptionofdigitalmedicineplatforms
AT velligandawni prescriberattitudesexperiencesandproclivitiestowarddigitalmedicineandhowtheyinfluenceadoptionofdigitalmedicineplatforms
AT robinsondelbert prescriberattitudesexperiencesandproclivitiestowarddigitalmedicineandhowtheyinfluenceadoptionofdigitalmedicineplatforms
AT jaegerchris prescriberattitudesexperiencesandproclivitiestowarddigitalmedicineandhowtheyinfluenceadoptionofdigitalmedicineplatforms
AT carpenterwilliam prescriberattitudesexperiencesandproclivitiestowarddigitalmedicineandhowtheyinfluenceadoptionofdigitalmedicineplatforms
AT formafelica prescriberattitudesexperiencesandproclivitiestowarddigitalmedicineandhowtheyinfluenceadoptionofdigitalmedicineplatforms